Sentences with phrase «translational tumor research»
Tags: Andrew Hsieh, Biostatistics and Biomathematics Program, Cancer etiology - prevention - outcomes, Cancer Prevention Program, Cancer Surveillance System, Christopher J Kemp, Good News, Kevin Cheung, Marian Neuhouser, metastatic breast cancer, Peggy Porter, Peter Nelson, Public Health Sciences, Roland Walter, Ruth Etzioni, Sage Bionetworks, SCCA, Seattle Cancer Care Alliance (SCCA), Seattle Translational Tumor Research, STTR cancer, Tumor specific translational research, UW Medicine
http://www.fredhutch.org/ Not exact matches
A team under Professor Scheffler, consisting of researchers from the Bonn University Hospital, the Life & Brain Center, The German Consortium for Translational Cancer Research, Tufts University Boston / Massachusetts, and other institutes in the USA, has now developed a new method that is expected to combat such complex brain tumors better.
The lab of co-author Dr. Robert Bast Jr., an expert in ovarian cancer and vice president for translational research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.
The finding warrants research into adding drugs that could prevent the cancer from hijacking patients» repressive gene regulatory machinery, which might allow the original therapy to work long enough to eradicate the tumor, the researchers report in their National Institutes of Health - funded study, published in the current issue of Science Translational Medicine.
Joining forces with dermatologists and oncologists from the University Hospital in Zurich and backed by the University Research Priority Program «Translational Cancer Research,» Sommer's team was able to demonstrate that, in melanoma cells, the epigenetic factor EZH2 controls genes that govern tumor growth as well as genes that are important for the formation of metastases.
Mass General geneticist Dora Dias - Santagata explains that she and other pathologists at the hospital's Translational Research Laboratory examine patients» tumors for more than 150 cancer - inducing mutations.
«RNAi therapies are a unique approach to cancer treatment as they have the potential to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth.»
Purpose: The development of the UNC Immuno - Oncology Patient Centered Translational Research (IMPACT) Biorepository involves the collection of tumor tissue and blood, as well as data (e.g., demographic, clinical, questionnaire) from patients attending Oncology Clinics at UNC Hospital and undergoing immune therapy through participation in a Merck IT trial at UNC.
The Clinical Accelerator, building on 60 + years of CRI's dedication to funding the most innovative basic science in tumor immunology, enables experts to advance their most ambitious clinical and translational research ideas to cure cancer, and accelerates studies that one group or company could not do alone.
Before he joined Moderna in 2013, Dr. Frederick was a Translational Research group leader at Aveo Oncology, focused on the generation of biomarkers for therapeutic response prediction, as well as avenues to modulate the tumor microenvironment for therapeutic benefit.
Tags: Acute Myeloid Leukemia, Andrew Hsieh, Basic Sciences, Clinical Research, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational research, Vaccine development - ViralResearch, Harmit Malik, Human Biology, Jesse Bloom, Marie Bleakley, Prostate Cancer, Transplant and Immunotherapy, Tumor specific translational research, Vaccine development - Viralresearch, Vaccine development - Viral cancers
Our clinicians work closely with our scientists on basic, clinical, and translational research activities in an effort to advance our understanding of these unique tumors.
Solid tumors, such as those of breast and ovaries, are the focus of Solid Tumor Translational Research, a network comprised of Fred Hutchinson Cancer Research Center, UW Medicine and Seattle Cancer Care Alliance.
These models are used for both basic and translational research, including studies to investigate the role of tumor initiating cells in tumor relapse, tumor metastasis and therapy resistance.
Research in the Immunology, Microenvironment and Metastasis program is aimed at 1) merging basic mechanistic understanding of multidisciplinary pathways of host - tumor interactions and metastatic dissemination with novel translational opportunities for diseases diagnosis and immunotherapy, as well as 2) investigating mechanisms regulating immune responses in cancer and their potential therapeutic manipulation.
Yet its contribution to tumor cell proliferation only increases the evidence that changes in metabolism are a cause of cancer and not just a consequence, according to Leif Ellisen, a cancer genetics researcher and oncologist who directs the MGH Translational Research Laboratory.
Tags: Acute Myeloid Leukemia, Anne McTiernan, cancer prevention, Computational Biology, exercise, genetic mutation, Harlan Robins, Human Biology, Lung Cancer, national science foundation, obesity, Pancreatic Cancer, physical activity, Public Health Sciences, stand up to cancer, Tumor specific translational research
Research fields include translational research, invasion, metastasis, disseminated tumor cells, transcription, tumor - associated proteolysis, targeted therapy, micro-RNA, molecular staging ofResearch fields include translational research, invasion, metastasis, disseminated tumor cells, transcription, tumor - associated proteolysis, targeted therapy, micro-RNA, molecular staging ofresearch, invasion, metastasis, disseminated tumor cells, transcription, tumor - associated proteolysis, targeted therapy, micro-RNA, molecular staging of cancer.
Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - ViralResearch, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viralresearch, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Fascinated by human immunology and translational research, I undertook my PhD in tumor immunology at the University of Tuebingen (Germany).
Dr. Tan specializes in management of tumors of the: - Pancreas (including cysts & chronic pancreatitis)- Liver (primary & metastatic)- Stomach - Duodenum and small intestine (including carcinoid tumors)- Bile duct and gallbladder - Retroperitoneum (including sarcomas) Dr. Tan performs clinical and translational research in pancreatic neoplasms and metastatic colorectal cancer.
The University of Michigan is a national leader in basic, translational, and clinical research on pediatric brain tumors.
The clinical biostatistics team has strong connection with the Biometry department (Head A. Savignoni), the early phase clinical trial and precision medicine unit where patients are treated with drugs in development (Head C. Le Tourneau), the translational research department in particular the Circulating Tumor Biomarkers laboratory (Charlotte Proudhon), and of course the other teams of the U900.
We identify and advance therapeutics into clinical trials for children with brain cancer, with increasing focus on types of brain tumors that are uncommon and have the greatest need for translational research.
In this eBook, we examine the complexity of the tumor microenvironment, explore technologies that are innovating basic and translational research, and strategies that are advancing immunotherapy into the clinic.
Dr. Gastier - Foster also has significant translational research funding to support the integration of genetic / genomic testing into clinical trials and promote biobanking and tumor processing for new research discoveries.
Young Kim, M.D., Ph.D., Associate Professor of Otolaryngology and co-leader of the Translational Research and Interventional Oncology Research Program, is a clinician - scientist focused on the development of immunotherapeutic modalities for solid tumors.
Tags: Amanda Paulovich, Clinical Research, infectious disease, Michael Boeckh, Ovarian Cancer, Pancreatic Cancer, proteomics, Seattle Cancer Care Alliance (SCCA), Sunil Hingorani, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine DevResearch, infectious disease, Michael Boeckh, Ovarian Cancer, Pancreatic Cancer, proteomics, Seattle Cancer Care Alliance (SCCA), Sunil Hingorani, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine Devresearch, Vaccine and Infectious Disease, Vaccine Development
In 2016, Dmitry I. Gabrilovich, M.D., Ph.D., program leader of Wistar's Translational Tumor Immunology program, and his research team identified a marker for myeloid - derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotheTumor Immunology program, and his research team identified a marker for myeloid - derived suppressor cells (MDSCs), a population of immune cells implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunothetumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.
Tags: cancer genomics, Carla Grandori, Christopher J Kemp, Clinical Research, Eddie Mendez, Good News, head neck cancers, Human Biology, Jerald P Radich, personalized treatment, precision medicine, Tumor specific translational research, VijayakrisResearch, Eddie Mendez, Good News, head neck cancers, Human Biology, Jerald P Radich, personalized treatment, precision medicine, Tumor specific translational research, Vijayakrisresearch, Vijayakrishna Gadi
She is active in a number of clinical and translational research projects, including the use of near - infrared fluorescent imaging in the surgical treatment of various diseases and application of minimally invasive tumor ablation in veterinary patients, and has authored numerous scientific publications and chapters in various veterinary textbooks.
Dr. Choy's professional interests include lymphoma, transitional cell carcinoma, localized tumor treatment with electrochemotherapy and translational cancer research through cooperative clinical trials and research projects with both local and national institutions including the Fred Hutchinson Cancer Research Center to improve patient care in both animals and theirresearch through cooperative clinical trials and research projects with both local and national institutions including the Fred Hutchinson Cancer Research Center to improve patient care in both animals and theirresearch projects with both local and national institutions including the Fred Hutchinson Cancer Research Center to improve patient care in both animals and theirResearch Center to improve patient care in both animals and their owners.